Failing the Public Health — Rofecoxib, Merck, and the FDA

Topol. (2004). Failing the Public Health — Rofecoxib, Merck, and the FDA. New England Journal of Medicine.

Type

Journal article

Intellectual base

Primary research

Year

2004

DOI

10.1056/nejmp048286

Link

https://doi.org/10.1056/nejmp048286

Cited by

1 citation across 1 artifact.

Domain-specific

• Adverse Drug Event
  • Merck voluntarily withdrew it worldwide in September 2004

Verification

This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.

Registry ID ref:331e2f1c7c8c · see in the full table